Vince Popolizio

Divergent outcomes of anti-PD-L1 treatment coupled with host-intrinsic differences in TCR repertoire and distinct T cell activation states in responding versus non-responding tumors

Zhangguo Chen, J. John, Samantha M. Y. Chen, 2022, Frontiers in Immunology.

Differential responses to immune checkpoint inhibitor dictated by pre-existing differential immune profiles in squamous cell carcinomas caused by same initial oncogenic drivers

D. Gao, Silvia Liu, Etienne Danis, 2022, Journal of Experimental & Clinical Cancer Research.

TRAF3 Acts as a Checkpoint of B Cell Receptor Signaling to Control Antibody Class Switch Recombination and Anergy

P. Xie, Zhangguo Chen, Samantha M. Y. Chen, 2020, The Journal of Immunology.

Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts

A. Jimeno, D. Gao, Zhangguo Chen, 2021, Journal for ImmunoTherapy of Cancer.